当前位置:首页 - 行情中心 - 启迪药业(000590) - 财务分析 - 利润表

启迪药业

(000590)

  

流通市值:17.86亿  总市值:17.86亿
流通股本:2.39亿   总股本:2.39亿

利润表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、营业总收入404,647,908.22274,629,835.65190,050,700.64101,199,883.45
营业收入404,647,908.22274,629,835.65190,050,700.64101,199,883.45
二、营业总成本392,810,851.45268,572,599.48183,610,777.2894,851,970.71
营业成本192,529,080.49130,212,461.788,249,882.9647,280,009.71
税金及附加8,724,866.46,250,763.184,221,247.852,142,172.64
销售费用89,815,553.4264,758,425.5845,756,935.0422,923,928.51
管理费用86,815,799.7456,559,909.2338,271,056.4819,162,287.67
研发费用12,819,682.619,252,948.846,093,258.483,035,083.94
财务费用2,105,868.791,538,090.951,018,396.47308,488.24
其中:利息费用4,462,326.523,496,062.912,434,338.831,051,034.62
其中:利息收入2,239,901.11,855,609.591,356,445.27686,959.78
加:公允价值变动收益1,900,000---
加:投资收益885,859.93612,079.76461,245.56346,628.9
资产处置收益13,328,503.04154,295.4168,512.15149,079.24
资产减值损失(新)-6,381,356.61---
信用减值损失(新)-7,957,658.62-156,499.41-425,721.23-4,509.91
其他收益6,547,295.152,826,864.032,340,139.511,436,069.61
营业利润平衡项目0000
四、营业利润20,159,699.669,493,975.958,984,099.358,275,180.58
加:营业外收入9,723,282.215,731.1512,371.13840.64
减:营业外支出203,741.8717,931.62,362.061,715.52
利润总额平衡项目0000
五、利润总额29,679,239.999,491,775.58,994,108.428,274,305.7
减:所得税费用4,789,040.242,914,515.362,537,092.281,665,795.09
六、净利润24,890,199.756,577,260.146,457,016.146,608,510.61
持续经营净利润24,890,199.756,577,260.146,457,016.146,608,510.61
归属于母公司股东的净利润25,246,778.766,430,149.786,382,540.846,584,800.39
少数股东损益-356,579.01147,110.3674,475.323,710.22
(一)基本每股收益0.110.030.030.03
(二)稀释每股收益0.110.030.030.03
九、综合收益总额24,890,199.756,577,260.146,457,016.146,608,510.61
归属于母公司股东的综合收益总额25,246,778.766,430,149.786,382,540.846,584,800.39
归属于少数股东的综合收益总额-356,579.01147,110.3674,475.323,710.22
公告日期2024-03-282023-10-282023-08-232023-04-26
审计意见(境内)标准无保留意见
TOP↑